Page 49 - Read Online
P. 49

Cangemi et al. Mini-invasive Surg 2022;6:3  https://dx.doi.org/10.20517/2574-1225.2021.99  Page 11 of 13

               20.      Vahanian A, Beyersdorf F, Praz F, et al; ESC/EACTS Scientific Document Group, ESC Scientific Document Group. 2021
                   ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J ;2021:ehab395.  DOI  PubMed
               21.      Otto CM, Nishimura RA, Bonow RO, et al; Writing Committee Members. 2020 ACC/AHA Guideline for the management of patients
                   with valvular heart disease: executive summary: a report of the American college of Cardiology/American Heart Association Joint
                   Committee on clinical practice guidelines. J Am Coll Cardiol 2021;77:450-500.  DOI  PubMed
               22.      Khawaja MZ, Wang D, Pocock S, Redwood SR, Thomas MR. The percutaneous coronary intervention prior to transcatheter aortic
                   valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial. Trials 2014;15:300.  DOI  PubMed  PMC
               23.      Patterson T, Clayton T, Dodd M, et al; ACTIVATION Trial Investigators. ACTIVATION (PercutAneous Coronary inTervention prIor
                   to transcatheter aortic VAlve implantaTION): a randomized clinical trial. JACC Cardiovasc Interv 2021;14:1965-74.  DOI  PubMed
               24.      Søndergaard L, Popma JJ, Reardon MJ, et al; SURTAVI Trial Investigators. Comparison of a complete percutaneous versus surgical
                   approach to aortic valve replacement and revascularization in patients at intermediate surgical risk: results from the randomized
                   SURTAVI trial. Circulation 2019.  DOI  PubMed
               25.      Barbanti M, Buccheri S, Capodanno D, et al; OBSERVANT Research Group. Transcatheter or surgical treatment of severe aortic
                   stenosis and coronary artery disease: a comparative analysis from the Italian OBSERVANT study. Int J Cardiol 2018;270:102-6.  DOI
                   PubMed
               26.      Kotronias RA, Bray JH, Scarsini R, et al. Transcatheter aortic valve replacement and percutaneous coronary intervention versus
                   surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary
                   artery disease: a systematic review and meta-analysis. Catheter Cardiovasc Interv 2020;96:1113-25.  DOI  PubMed
               27.      Barbato E, Toth GG, Johnson NP, et al. A prospective natural history study of coronary atherosclerosis using fractional flow reserve. J
                   Am Coll Cardiol 2016;68:2247-55.  DOI  PubMed
               28.      van Nunen LX, Zimmermann FM, Tonino PAL, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with
                   multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 2015;386:1853-60.  DOI
                   PubMed
               29.      Fearon WF, Nishi T, De Bruyne B, et al; FAME 2 Trial Investigators. Clinical outcomes and cost-effectiveness of fractional flow
                   reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: three-year follow-up of the FAME 2
                   trial (fractional flow reserve versus angiography for multivessel evaluation). Circulation 2018;137:480-7.  DOI  PubMed
               30.      Knuuti J, Wijns W, Saraste A, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of
                   chronic coronary syndromes. Eur Heart J 2020;41:407-77.  DOI  PubMed
               31.      Rajappan K, Rimoldi OE, Dutka DP, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and
                   angiographically normal coronary arteries. Circulation 2002;105:470-6.  DOI  PubMed
               32.      Eberli FR, Ritter M, Schwitter J, et al. Coronary reserve in patients with aortic valve disease before and after successful aortic valve
                   replacement. Eur Heart J 1991;12:127-38.  DOI  PubMed
               33.      Stoller M, Gloekler S, Zbinden R, et al. Left ventricular afterload reduction by transcatheter aortic valve implantation in severe aortic
                   stenosis and its prompt effects on comprehensive coronary haemodynamics. EuroIntervention 2018;14:166-73.  DOI  PubMed
               34.      Scarsini R, De Maria GL, Di Gioia G, et al. The influence of aortic valve obstruction on the hyperemic intracoronary physiology:
                   difference between resting Pd/Pa and FFR in aortic stenosis. J Cardiovasc Transl Res 2019;12:539-50.  DOI  PubMed
               35.      Pesarini G, Scarsini R, Zivelonghi C, et al. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic
                   valve implantation: influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv 2016;9:e004088.  DOI
                   PubMed
               36.      Lunardi M, Scarsini R, Venturi G, et al. Physiological versus angiographic guidance for myocardial revascularization in patients
                   undergoing transcatheter aortic valve implantation. J Am Heart Assoc 2019;8:e012618.  DOI  PubMed  PMC
               37.      Ahmad Y, Götberg M, Cook C, et al. Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease
                   undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC Cardiovasc
                   Interv 2018;11:2019-31.  DOI  PubMed  PMC
               38.      Yamanaka F, Shishido K, Ochiai T, et al. Instantaneous wave-free ratio for the assessment of intermediate coronary artery stenosis in
                   patients with severe aortic valve stenosis: comparison with myocardial perfusion scintigraphy. JACC Cardiovasc Interv 2018;11:2032-
                   40.  DOI  PubMed
               39.      Scarsini R, Cantone R, Venturi G, et al. Correlation between intracoronary physiology and myocardial perfusion imaging in patients
                   with severe aortic stenosis. Int J Cardiol 2019;292:162-5.  DOI  PubMed
               40.      Scarsini R, Pesarini G, Lunardi M, et al. Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic
                   stenosis and coronary artery disease undergoing TAVI. Cardiovasc Revasc Med 2018;19:355-9.  DOI  PubMed
               41.      Goel SS, Agarwal S, Tuzcu EM, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for
                   transcatheter aortic valve replacement. Circulation 2012;125:1005-13.  DOI  PubMed
               42.      Faroux L, Campelo-Parada F, Munoz-Garcia E, et al. Procedural characteristics and late outcomes of percutaneous coronary
                   intervention in the workup pre-TAVR. JACC Cardiovasc Interv 2020;13:2601-13.  DOI  PubMed
               43.      van Rosendael PJ, van der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter
                   aortic valve implantation. Am J Cardiol 2015;115:1726-32.  DOI  PubMed
               44.      Venturi G, Pighi M, Pesarini G, et al. Contrast-induced acute kidney injury in patients undergoing TAVI compared with coronary
                   interventions. J Am Heart Assoc 2020;9:e017194.  DOI  PubMed  PMC
               45.      Barbanti M, Todaro D, Costa G, et al. Optimized screening of coronary artery disease with invasive coronary angiography and ad hoc
                   percutaneous coronary intervention during transcatheter aortic valve replacement. Circ Cardiovasc Interv 2017;10:e005234.  DOI
   44   45   46   47   48   49   50   51   52   53   54